ASX Announcement 19 October 2026 BCAL Diagnostics presents BREASTESTplus research at International Lipidomic Conference Highlights • BCAL's research underpinning BREASTESTplus™ 2 has been presented as a scientific poster at the Australian Lipid Meeting and International Lipidomic Society...
BREASTESTplus Research Presented at Lipidomic Conference
Filed with ASX ·
6ix hasn’t read this filing yet.
BCAL Diagnostics Limited on 6ix
In the deck
Earlier from BCAL Diagnostics
- GSS: Response to Media Speculation & BCAL letter to GSS
- Letter to Genetic Signatures Ltd Shareholders
- Investor Presentation - Transforming Cancer Detection
- Change in substantial holding
- BREASTESTplus 2 clinically validated
Later from BCAL Diagnostics
- AGM 2026 Presentation
- Results of Meeting
- BCAL Welcomes Dr John Melki's Appointment to GSS Board
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics